These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12474761)

  • 1. [Osteoporosis: diagnosis and treatment of vertebral fractures].
    Baranauskaite A
    Medicina (Kaunas); 2002; 38(8):862-5; quiz 866. PubMed ID: 12474761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bisphosphonate treatment prevents hip fractures in 70-79 year old women with osteoporotic vertebral fractures].
    Netelenbos JC
    Ned Tijdschr Geneeskd; 2001 Jul; 145(28):1336-8. PubMed ID: 11484428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risedronate increases bone mineral density and reduces the vertebral fracture incidence in postmenopausal women.
    Reginster JY
    Clin Exp Rheumatol; 2001; 19(2):121-2. PubMed ID: 11326471
    [No Abstract]   [Full Text] [Related]  

  • 4. [Osteoporosis in the elderly--diagnosis and treatment].
    Gärtner R
    MMW Fortschr Med; 2005 Feb; 147(7):33, 35-6. PubMed ID: 18441582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vertebral body fracture as incidental finding in thoracic radiography. Family physician usually does not learn about it].
    MMW Fortschr Med; 2003 Feb; 145(8):55. PubMed ID: 12661447
    [No Abstract]   [Full Text] [Related]  

  • 6. Risedronate treatment and extended fracture protection in postmenopausal women.
    Harris ST
    Clin Exp Rheumatol; 2001; 19(6):625-6. PubMed ID: 11791630
    [No Abstract]   [Full Text] [Related]  

  • 7. [Faster and long-lasting protection with risedronate. With strengthened bones longer self-sufficient].
    MMW Fortschr Med; 2004 May; 146(22):52-3. PubMed ID: 15373118
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women.
    Kanis JA; Borgstrom F; Johnell O; Jonsson B
    Osteoporos Int; 2004 Nov; 15(11):862-71. PubMed ID: 15175846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risedronate, a new diphosphonate in osteoporosis and Paget's disease].
    Bannwarth B
    Presse Med; 2002 Mar; 31(8):340-2. PubMed ID: 11913075
    [No Abstract]   [Full Text] [Related]  

  • 11. Risedronate prevents new vertebral fractures in postmenopausal women at high risk.
    Watts NB; Josse RG; Hamdy RC; Hughes RA; Manhart MD; Barton I; Calligeros D; Felsenberg D
    J Clin Endocrinol Metab; 2003 Feb; 88(2):542-9. PubMed ID: 12574177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [VERT(Vertebral Efficacy with Risedronate Therapy)-MN(Multinational) Study and VERT-NA(North America) Study].
    Fukunaga M
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():433-6. PubMed ID: 15035166
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old.
    Boonen S; McClung MR; Eastell R; El-Hajj Fuleihan G; Barton IP; Delmas P
    J Am Geriatr Soc; 2004 Nov; 52(11):1832-9. PubMed ID: 15507059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: greater risk, greater benefit--true or false?
    Miller PD
    J Clin Endocrinol Metab; 2003 Feb; 88(2):538-41. PubMed ID: 12574176
    [No Abstract]   [Full Text] [Related]  

  • 15. Risedronate reduces the risk of first vertebral fracture in osteoporotic women.
    Heaney RP; Zizic TM; Fogelman I; Olszynski WP; Geusens P; Kasibhatla C; Alsayed N; Isaia G; Davie MW; Chesnut CH
    Osteoporos Int; 2002; 13(6):501-5. PubMed ID: 12107665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [To treat effectively without delay. The data on fractures decisive].
    MMW Fortschr Med; 2003 May; 145(21):56-7. PubMed ID: 12845873
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trial.
    Fukunaga M; Kushida K; Kishimoto H; Shiraki M; Taketani Y; Minaguchi H; Inoue T; Morita R; Morii H; Yamamoto K; Ohashi Y; Orimo H;
    Osteoporos Int; 2002 Dec; 13(12):971-9. PubMed ID: 12459940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture.
    Kanis JA; Barton IP; Johnell O
    Osteoporos Int; 2005 May; 16(5):475-82. PubMed ID: 15875093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
    Seibel MJ; Naganathan V; Barton I; Grauer A
    J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Osteoporosis: diagnosis, prevention and treatment].
    Baranauskaite A; Savickiene A
    Medicina (Kaunas); 2002; 38(2):234-9; quiz 240. PubMed ID: 12474746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.